S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
S&P 500   0.66 (+14.63%)
DOW   0.66 (+14.63%)
QQQ   265.19 (-1.89%)
AAPL   437.50 (-2.97%)
MSFT   203.38 (-2.34%)
FB   256.13 (-2.61%)
GOOGL   1,480.54 (-1.09%)
AMZN   3,080.67 (-2.14%)
NVDA   434.00 (-2.82%)
CGC   16.95 (-5.47%)
BABA   248.42 (+0.12%)
TSLA   1,374.39 (-3.11%)
GE   6.73 (+0.90%)
MU   47.76 (-2.83%)
AMD   76.88 (-6.52%)
T   30.20 (-0.03%)
F   7.23 (+1.97%)
ACB   10.02 (-1.96%)
GILD   68.10 (-0.60%)
NFLX   466.93 (-3.40%)
DIS   130.49 (+1.32%)
BAC   26.92 (+1.36%)
BA   180.13 (+0.40%)
Log in

NASDAQ:NVSTEnvista Stock Price, Forecast & News

$23.14
+0.26 (+1.14 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$23.08
Now: $23.14
$23.55
50-Day Range
$19.71
MA: $21.47
$23.37
52-Week Range
$10.08
Now: $23.14
$33.30
Volume1.17 million shs
Average Volume2.96 million shs
Market Capitalization$3.69 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Envista Holdings Corporation manufactures and sells dental products in the United States and internationally. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics, as well as provides a comprehensive education program. Its Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. The segment sells its products under the KaVo umbrella brand name through dental distributors. The company was incorporated in 2018 and is headquartered in Brea, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.14 out of 5 stars


Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NVST
CUSIPN/A
CIKN/A
Phone714-817-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees12,000
Market Cap$3.69 billion
Next Earnings Date10/22/2020 (Estimated)
OptionableNot Optionable
$23.14
+0.26 (+1.14 %)
(As of 08/11/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NVST News and Ratings via Email

Sign-up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Envista (NASDAQ:NVST) Frequently Asked Questions

How has Envista's stock been impacted by COVID-19 (Coronavirus)?

Envista's stock was trading at $19.93 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NVST shares have increased by 16.1% and is now trading at $23.14.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Envista?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Envista in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Envista
.

When is Envista's next earnings date?

Envista is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Envista
.

How were Envista's earnings last quarter?

Envista Holdings Corporation (NASDAQ:NVST) posted its quarterly earnings results on Thursday, July, 30th. The company reported ($0.10) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.24) by $0.14. The firm had revenue of $362 million for the quarter, compared to analyst estimates of $346.33 million.
View Envista's earnings history
.

What price target have analysts set for NVST?

11 brokerages have issued 12-month price objectives for Envista's stock. Their forecasts range from $21.00 to $35.00. On average, they anticipate Envista's stock price to reach $27.30 in the next year. This suggests a possible upside of 18.0% from the stock's current price.
View analysts' price targets for Envista
.

Has Envista been receiving favorable news coverage?

News articles about NVST stock have trended negative this week, InfoTrie reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Envista earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near term.
View the latest news about Envista
.

Who are some of Envista's key competitors?

What other stocks do shareholders of Envista own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Envista investors own include Walt Disney (DIS), Snap (SNAP), Wells Fargo & Co (WFC), AbbVie (ABBV), Amarin (AMRN), Bank of America (BAC), FedEx (FDX), Occidental Petroleum (OXY), Trade Desk (TTD) and Boeing (BA).

When did Envista IPO?

(NVST) raised $603 million in an IPO on Wednesday, September 18th 2019. The company issued 26,800,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley served as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

What is Envista's stock symbol?

Envista trades on the NASDAQ under the ticker symbol "NVST."

Who are Envista's major shareholders?

Envista's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Viking Global Investors LP (2.84%), Paradice Investment Management LLC (1.84%), First Trust Advisors LP (1.07%), Frontier Capital Management Co. LLC (0.89%), Dalton Greiner Hartman Maher & Co. (0.37%) and Aperture Investors LLC (0.36%). Company insiders that own Envista stock include Amir Aghdaei, Howard H Yu and Mischa Reis.
View institutional ownership trends for Envista
.

Which major investors are selling Envista stock?

NVST stock was sold by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Mackay Shields LLC, Amalgamated Bank, PNC Financial Services Group Inc., Vident Investment Advisory LLC, Vident Investment Advisory LLC, Sumitomo Mitsui Trust Holdings Inc., and Dalton Greiner Hartman Maher & Co..
View insider buying and selling activity for Envista
.

Which major investors are buying Envista stock?

NVST stock was acquired by a variety of institutional investors in the last quarter, including Viking Global Investors LP, Frontier Capital Management Co. LLC, First Trust Advisors LP, Aperture Investors LLC, Russell Investments Group Ltd., Paradice Investment Management LLC, Mesirow Financial Investment Management Equity Management, and Kornitzer Capital Management Inc. KS. Company insiders that have bought Envista stock in the last two years include Amir Aghdaei, Howard H Yu, and Mischa Reis.
View insider buying and selling activity for Envista
.

How do I buy shares of Envista?

Shares of NVST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Envista's stock price today?

One share of NVST stock can currently be purchased for approximately $23.14.

How big of a company is Envista?

Envista has a market capitalization of $3.69 billion. Envista employs 12,000 workers across the globe.

What is Envista's official website?

The official website for Envista is www.envistaco.com.

How can I contact Envista?

The company can be reached via phone at 714-817-7000.

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.